Skip to Main Content

We publish recommendations and resources, together with a host of other material for the benefit of our users.

A digest of NHS Specialist Pharmacy Service support for professionals working in all areas of the healthcare system for May 2026.
Know what medicines are in the pipeline. Understand the strategic and operational challenges for the NHS. Start planning early.
SPS PGD template for the insertion of etonogestrel (e.g. Nexplanon®) 68mg subdermal implant for contraception.
SPS PGD template for the supply and/or administration of subcutaneous medroxyprogesterone acetate (SC-DMPA) injection for contraception.
SPS protocol templates for the supply and administration of omeprazole for caesarean section by registered midwives.
PGD and VGD templates by UKHSA are developed for a range of clinical scenarios. A summary of the processes to use and further links are provided.
SPS PGD template for supply of doxycycline for the treatment of uncomplicated genital chlamydia trachomatis, LGV and non-gonococcal/non-specific urethritis.
Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot
E-learning developed by SPS in partnership with UKHSA, HEE and eLfH to support professionals who use, develop, authorise, review or update PGDs.
SPS PGD template for administering benzylpenicillin prior to transfer to secondary care in suspected bacterial meningitis or meningococcal septicaemia.
Using injectable medicines for multiple doses increases the risk of contamination, error and patient harm.
A digest of NHS Specialist Pharmacy Service support for professionals working in all areas of the healthcare system for May 2026.
Topical chloramphenicol can be used with caution and monitoring. Systemic chloramphenicol is not recommended. Advice applies to full term and healthy infants.
Best practice guidance for NHS hospital pharmacy procurement teams on managing a successful off-contract claims process.
All calcium channel blockers (CCBs) can cause peripheral oedema. Incidence varies by choice and patient factors. Several management options are available.
An SPS Quality Assurance (QA) bite size learning event on evaluating imported unlicensed medicines.
Delegation of any PGD function is not permitted. However there are specific tasks that individuals other than the professional working under a PGD can fulfil.
Resources for reviewing interactions with supplements and complementary, herbal and alternative products, including homeopathy, Chinese and Ayurvedic.
Know what medicines are in the pipeline. Understand the strategic and operational challenges for the NHS. Start planning early.
A resource collating the latest medication safety communications and publications to inform, support and inspire medication safety improvements.
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
Effective use provides assurance that an organisation is aware of the most critical medication safety related information, and acts on this to improve safety
Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot
E-learning developed by SPS in partnership with UKHSA, HEE and eLfH to support professionals who use, develop, authorise, review or update PGDs.
A report on the state of the pharmacy technical services workforce in the North of England
A checklist for audits and self-inspections for the holders of wholesale distribution authorisations
SPS have developed a template audit tool to support organisations in auditing aspects of PGD development and use.